223
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Risk Prediction of Dyslipidemia for Chinese Han Adults Using Random Forest Survival Model

, , , &
Pages 1047-1055 | Published online: 10 Dec 2019

References

  • Stamler J, Daviglus ML, Garside DB, Dyer AR, Greenland P, Neaton JD. Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. J Am Med Assoc. 2000;284(3):311–318. doi:10.1001/jama.284.3.311
  • Nelson RH. Hyperlipidemia as a risk factor for cardiovascular disease. Prim Care. 2013;40:195–211. doi:10.1016/j.pop.2012.11.00323402469
  • Ni W.Q, Liu X-L, Zhuo Z-P, et al. Serum lipids and associated factors of dyslipidemia in the adult population in Shenzhen. Lipids Health Dis. 2015;14:1–11. doi:10.1186/s12944-015-0073-725575766
  • Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation. 1998;97:596–601. doi:10.1161/01.CIR.97.6.5969494031
  • Miller M. Dyslipidemia and cardiovascular risk: the importance of early prevention. QJM. 2009;102:657–667. doi:10.1093/qjmed/hcp06519498039
  • Hendrani AD, Adesiyun T, Quispe R, et al. Dyslipidemia management in primary prevention of cardiovascular disease: current guidelines and strategies. World J Cardiol. 2016;8:201-210. doi:10.4330/wjc.v8.i2.20126981215
  • Costanza MC, Paccaud F. Binary classification of dyslipidemia from the waist-to-hip ratio and body mass index: a comparison of linear, logistic, and CART models. BMC Med Res Methodol. 2004;4:1–10. doi:10.1186/1471-2288-4-7
  • Wang CJ, Wang CJ, Li YQ, Wang L, et al. Development and evaluation of a simple and effective prediction approach for identifying those at high risk of dyslipidemia in rural adult residents. PLoS One. 2012;7:1–7.
  • Yamada Y, Matsuo H, Warita S, et al. Prediction of genetic risk for dyslipidemia. Genomics. 2007;90:551–558. doi:10.1016/j.ygeno.2007.08.00117919884
  • Marateb HR, Mohebian MR, Javanmard SH, et al. Prediction of dyslipidemia using gene mutations, family history of diseases and anthropometric indicators in children and adolescents: the CASPIAN-III study. Comput Struct Biotechnol J. 2018;16:121–130. doi:10.1016/j.csbj.2018.02.00930026888
  • Levy WC, Mozaffarian D, Linker DT, et al. The seattle heart failure model: prediction of survival in heart failure. Circulation. 2006;113:1424. doi:10.1161/CIRCULATIONAHA.105.58410216534009
  • Joo E-J, Chang Y, Yeom J-S, Cho YK, Ryu S. Chronic hepatitis B virus infection and risk of dyslipidemia: a cohort study. J Viral Hepat. 2019;26:162–169. doi:10.1111/jvh.1301430267602
  • Breiman L. Heuristics of instability and stabilization in model selection. Ann Stat. 1996;24:2350–2383. doi:10.1214/aos/1032181158
  • Lezcanovalverde JM, Salazar F, León L, et al. Development and validation of a multivariate predictive model for rheumatoid arthritis mortality using a machine learning approach. Sci Rep. 2017;7(1):10189.28860558
  • Breiman L. Bagging predictors. Mach Learn. 1996;24:123–140. doi:10.1007/BF00058655
  • Ishwaran H, Kogalur UB, Blackstone EH, Lauer MS. Random survival forests. Ann Appl Stat. 2008;2:841–860. doi:10.1214/08-AOAS169
  • Hamidi O, Tapak M, Poorolajal J, Amini P, Tapak L. Application of random survival forest for competing risks in prediction of cumulative incidence function for progression to AIDS. Epidemiol Biostat Public Heal. 2017;14:e12663-1–e12663-10.
  • Hu H, Nakagawa T, Yamamoto S, et al. Development and validation of risk models to predict the 7-year risk of type 2 diabetes: the Japan epidemiology collaboration on occupational health study. J Diabetes Investig. 2018;9(5):1–8. doi:10.1111/jdi.12809.
  • Dietrich S, Floegel A, Troll M, et al. Random survival forest in practice: a method for modelling complex metabolomics data in time to event analysis. Int J Epidemiol. 2016;45:1406–1420. doi:10.1093/ije/dyw14527591264
  • Zhu JR, Gao RL, Zhao SP, Lu GP, Zhao D, Li JJ. 2016 Chinese guidelines for the management of dyslipidemia in adults. J Geriatr Cardiol. 2018;15:1–29.29434622
  • Ehrlinger J ggRandomForests: exploring random forest survival. ArXiv Prepr ArXiv. 2016;1612.08974.
  • Harrell FE Jr, Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. JAMA. 1982;247:2543–2546. doi:10.1001/jama.1982.033204300470307069920
  • Yang W, Xiao J, Yang Z, et al. Serum lipids and lipoproteins in Chinese men and women. Circulation. 2012;125:2212–2221. doi:10.1161/CIRCULATIONAHA.111.06590422492668
  • Habib SS, Aslam M, Hameed W. Gender differences in lipids and lipoprotein (a) profiles in healthy individuals and patients with type 2 diabetes mellitus. Pak J Physiol. 2005;1(1–2).
  • Zhu Y, Shao Z, Jing J, et al. Body mass index is better than other anthropometric indices for identifying dyslipidemia in Chinese children with obesity. PLoS One. 2016;11:1–11.
  • Qi L, Ding X, Tang W, et al. Prevalence and risk factors associated with dyslipidemia in Chongqing, China. Int J Environ Res Public Health. 2015;12:13455–13465. doi:10.3390/ijerph12101345526516874
  • Datema FR, Moya A, Krause P, et al. Novel head and neck cancer survival analysis approach: random survival forests versus Cox proportional hazards regression. Head Neck. 2012;34:50–58. doi:10.1002/hed.2169821322080
  • Hsich E, Gorodeski EZ, Blackstone EH, Ishwaran H, Lauer MS. Identifying important risk factors for survival in systolic heart failure patients using random survival forests. Circ Cardiovasc Qual Outcomes. 2011;4:39–45. doi: 10.1161/CIRCOUTCOMES.110.93937121098782
  • Kurt Omurlu I, Ture M, Tokatli F. The comparisons of random survival forests and Cox regression analysis with simulation and an application related to breast cancer. Expert Syst Appl. 2009;36:8582–8588. doi:10.1016/j.eswa.2008.10.023
  • Hamidi O, Poorolajal J, Farhadian M, Tapak L. Identifying important risk factors for survival in kidney graft failure patients using random survival forests. Iran J Public Health. 2016;45:27–33.27057518